Amerigen Pharmaceuticals Limited announced the commercial launch of its generic bexarotene 75mg capsules following the recent approval of the Company’s corresponding Abbreviated New Drug Application (ANDA) by the U.S. Food and Drug Administration. Amerigen’s bexarotene product is a generic equivalent to Valeant Pharmaceuticals’ Targretin Capsules. Amerigen’s generic bexarotene capsules are marketed by Amerigen’s U.S. affiliate, Amerigen Pharmaceuticals, Inc.
(Source: Amerigen Pharmaceuticals Limited)
Filed Under: Drug Discovery
